Compile Data Set for Download or QSAR
Report error Found 85 Enz. Inhib. hit(s) with all data for entry = 10743
TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563072BDBM563072(US11407737, Example 18 | N-(2-hydroxyethyl)-N-meth...)
Affinity DataIC50: 1nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563076BDBM563076(US11407737, Example 20 | (3S)-N-[3-[2-(3-hydroxyaz...)
Affinity DataIC50: 1nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563074BDBM563074(US11407737, Example 19 | N,N-dimethyl-4-[2-methyl-...)
Affinity DataIC50: 1nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563080BDBM563080(US11407737, Example 22 | (3S)-N-[4-methyl-3-[2-(l-...)
Affinity DataIC50: 1nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563081BDBM563081(US11407737, Example 65 | (2R)-N-{4-methyl-3-[2-(2-...)
Affinity DataIC50: 1nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563078BDBM563078(US11407737, Example 21 | (3S)-N-[3-[2-(3-hydroxy-3...)
Affinity DataIC50: 1nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563052BDBM563052(US11407737, Example 8 | N-[(2S)-1-hydroxypropan-2-...)
Affinity DataIC50: 1nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563050BDBM563050(US11407737, Example 7 | N-[(2S)-2-hydroxypropyl]-4...)
Affinity DataIC50: 1nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563119BDBM563119(US11407737, Example 84 | (3R)-3-(1,1-difluoroethyl...)
Affinity DataIC50: 1nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563060BDBM563060(US11407737, Example 12 | (3S)-N-(3-[2-[(3R)-3-hydr...)
Affinity DataIC50: 1nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563062BDBM563062(US11407737, Example 13 | (3S)-N-(3-[2-[(1R,2S)-2- ...)
Affinity DataIC50: 1nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563101BDBM563101(US11407737, Example 75 | (3R)-N-{2-fluoro-4-methyl...)
Affinity DataIC50: 1nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563099BDBM563099(US11407737, Example 74 | (3S)-N-{2-fluoro-4-melhyl...)
Affinity DataIC50: 1nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563104BDBM563104(US11407737, Example 34 | (3S)-N-(4-methyl-3-(2-mor...)
Affinity DataIC50: 1nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563105BDBM563105(US11407737, Example 77 | N-{2-fluoro-4-methyl-5-[2...)
Affinity DataIC50: 1nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563102BDBM563102(US11407737, Example 33 | (3S)-N-[4-methyl-3-[2-(mo...)
Affinity DataIC50: 1nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563103BDBM563103(US11407737, Example 76 | (3S)-N-{2-fluoro-4-methyl...)
Affinity DataIC50: 1nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563108BDBM563108(US11407737, Example 36 | (3S)-N-[4-methyl-3-[2-(1-...)
Affinity DataIC50: 1nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563107BDBM563107(US11407737, Example 78 | (3S)-N-{3-[2-(1-ethylpyra...)
Affinity DataIC50: 1nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563049BDBM563049(US11407737, Example 49 | (3S)-N-[4-methyl-3-[2-(2-...)
Affinity DataIC50: 1nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563047BDBM563047(US11407737, Example 48 | (3S)-N-[3-[2-(1,5-dimethy...)
Affinity DataIC50: 1nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563084BDBM563084(US11407737, Example 24 | (3S)-N-[3-[2-(3-hydroxypr...)
Affinity DataIC50: 1nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563085BDBM563085(US11407737, Example 67 | (2S)-N-{2-fluoro-4-methyl...)
Affinity DataIC50: 1nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563082BDBM563082(US11407737, Example 23 | (3S)-N-(3-[2-[(1E)-3-hydr...)
Affinity DataIC50: 1nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563083BDBM563083(US11407737, Example 66 | N-{4-methyl-3-[2-(1-methy...)
Affinity DataIC50: 1nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563088BDBM563088(US11407737, Example 26 | (3S)-N-[3-[2-(2-hydroxy-1...)
Affinity DataIC50: 1nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563089BDBM563089(US11407737, Example 69 | N-{2-fluoro-4-methyl-5-[2...)
Affinity DataIC50: 1nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563086BDBM563086(US11407737, Example 25 | (3S)-N-[3-[2-methoxy-6-(m...)
Affinity DataIC50: 1nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563087BDBM563087(US11407737, Example 68 | (2R)-N-{2-fluoro-4-methyl...)
Affinity DataIC50: 1nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563093BDBM563093(US11407737, Example 71 | (3S)-N-{5-[2-cyclopropyl-...)
Affinity DataIC50: 1nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563091BDBM563091(US11407737, Example 70 | (3S)-N-{2-fluoro-4-methyl...)
Affinity DataIC50: 1nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563097BDBM563097(US11407737, Example 73 | N-{2-fluoro-4-methyl-5-[2...)
Affinity DataIC50: 1nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563095BDBM563095(US11407737, Example 72 | (3S)-N-{5-[2-ethyl-6-(mor...)
Affinity DataIC50: 1nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563116BDBM563116(US11407737, Example 40 | (3S)-N-[3-[2'-amino-6-(mo...)
Affinity DataIC50: 5.5nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563117BDBM563117(US11407737, Example 83 | (3R)-3-tertyl-N-{2-fluoro...)
Affinity DataIC50: 5.5nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563114BDBM563114(US11407737, Example 39 | (S)-N-(4-methyl-3-(2-(1-m...)
Affinity DataIC50: 5.5nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563115BDBM563115(US11407737, Example 82 | (3S)-3-tert-butyl-N-{2-fl...)
Affinity DataIC50: 5.5nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563120BDBM563120(US11407737, Example 42 | (3S)-N-[4-methyl-3-[2-(mo...)
Affinity DataIC50: 5.5nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563121BDBM563121(US11407737, Example 85 | N-{2-fluoro-4-methyl-5-[2...)
Affinity DataIC50: 5.5nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563118BDBM563118(US11407737, Example 41 | (3S)-N-(3-[2-[1-(difluoro...)
Affinity DataIC50: 5.5nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563122BDBM563122(US11407737, Example 43Biochemical)
Affinity DataIC50: 5.5nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 562900BDBM562900(US11407737, Example 2 | 4-[2-methyl-5-[(3S)-3-(2,2...)
Affinity DataIC50: 5.5nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563041BDBM563041(US11407737, Example 45 | (3S)-N-[3-[2-(2-aminopyri...)
Affinity DataIC50: 5.5nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 562894BDBM562894(US11407737, Example 1 | (3S)-N-[4-methyl-3-[2-meth...)
Affinity DataIC50: 5.5nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 562899BDBM562899(US11407737, Example 44 | (3S)-N-[3-[2-(5-amino-1-m...)
Affinity DataIC50: 5.5nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563044BDBM563044(US11407737, Example 4 | N-(2-hydroxyethyl)-4-[2-me...)
Affinity DataIC50: 5.5nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563045BDBM563045(US11407737, Example 47 | (3S)-N-[4-methyl-3-[2-(3-...)
Affinity DataIC50: 5.5nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563042BDBM563042(US11407737, Example 3 | N-methyl-4-[2-methyl-5-[(3...)
Affinity DataIC50: 5.5nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563043BDBM563043(US11407737, Example 46 | (3S)-N-[3-[2'-(difluorome...)
Affinity DataIC50: 5.5nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Kinnate Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 563048BDBM563048(US11407737, Example 6 | N-[(2R)-1-hydroxypropan-2-...)
Affinity DataIC50: 5.5nMAssay Description:Assay platform was used to measure kinase/inhibitor interactions as described previously (Anastassiadis et al., 2011). In brief, for each reaction, k...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent

Displayed 1 to 50 (of 85 total ) | Next | Last >>
Jump to: